Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product (PM:NYSE)

Core Viewpoint - Philip Morris International is seeking approval from the U.S. Food and Drug Administration to market its heated tobacco products as a "modified risk tobacco product" in the U.S. [2] Group 1 - The company emphasizes the benefits of heating tobacco instead of burning it, which is a key aspect of its product differentiation [2]